Encompass Health Corp [EHC] stock prices are up 1.27% to $86.37 at the moment. An important factor to consider is whether the stock is rising or falling in short-term value. The EHC shares have gain 3.54% over the last week, with a monthly amount glided 5.88%, and seem to be holding up well over a long-time horizon.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
From an analyst’s perspective:
Encompass Health Corp [NYSE: EHC] stock has seen the most recent analyst activity on March 06, 2024, when Barclays initiated its Overweight rating and assigned the stock a price target of $95. Previously, Barclays started tracking the stock with Equal Weight rating on March 14, 2023, and set its price target to $57. On September 24, 2021, UBS initiated with a Buy rating and assigned a price target of $98 on the stock. Raymond James upgraded its rating to a Strong Buy and increased its price target to $107 on August 02, 2021. Barclays upgraded its rating to a Overweight but $96 remained the price target by the analyst firm on November 23, 2020. In a note dated December 11, 2019, Wells Fargo downgraded an Underperform rating on this stock.
The stock price of Encompass Health Corp [EHC] has been fluctuating between $57.55 and $86.60 over the past year. Currently, Wall Street analysts expect the stock to reach $91.5 within the next 12 months. Encompass Health Corp [NYSE: EHC] shares were valued at $86.37 at the most recent close of the market. An investor can expect a potential return of 5.94% based on the average EHC price forecast.
Analyzing the EHC fundamentals
The Encompass Health Corp [NYSE:EHC] reported sales of 4.96B for trailing twelve months, representing a surge of 13.41%. Gross Profit Margin for this corporation currently stands at 0.56% with Operating Profit Margin at 0.13%, Pretax Profit Margin comes in at 0.13%, and Net Profit Margin reading is 0.08%. To continue investigating profitability, this company’s Return on Assets is posted at 0.06, Equity is 0.23 and Total Capital is 0.11. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of1.39.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 85.41 points at the first support level, and at 84.44 for the second support level. However, for the 1st resistance point, the stock is sitting at 86.93, and for the 2nd resistance point, it is at 87.48.
Encompass Health Corp [EHC] reported earnings per share of $1.12 for its fiscal quarter that ended on 3/31/2024. Based on the Wall Street analysts’ estimates, the company was expected to report earnings of $0.94/share, meaning a difference of $0.18 and a surprise factor of 19.10%. By comparison, the stated earnings for the previous quarter ended on 12/31/2023 were $0.95 per share as compared to estimates of $0.82 per share, a difference of $0.13 representing a surprise of 15.90%.
Ratios To Look Out For
It’s worth pointing out that Encompass Health Corp [NYSE:EHC]’s Current Ratio is 1.37. On the other hand, the Quick Ratio is 1.37, and the Cash Ratio is 0.25. Considering the valuation of this stock, the price to sales ratio is 1.75, the price to book ratio is 4.99 and price to earnings (TTM) ratio is 23.29.
Transactions by insiders
Recent insider trading involved Darby John Patrick, EVP, Gen Counsel & Secretary, that happened on May 06 ’24 when 14543.0 shares were sold. Director, CARMICHAEL GREG D completed a deal on May 03 ’24 to buy 2000.0 shares. Meanwhile, President & CEO Tarr Mark J sold 44976.0 shares on Apr 30 ’24.
